D-607-2013 Class III Terminated
FDA drug recall D-607-2013 was initiated by Pfizer Inc on May 31, 2013 and is designated Class III. Reason for recall: Failed Dissolution Specification The recall status is terminated (terminated Jun 5, 2015). Affected quantity: 5,410 botlles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 26, 2013
- Initiation Date
- May 31, 2013
- Termination Date
- Jun 5, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,410 botlles
Product description
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.
Reason for recall
Failed Dissolution Specification
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: a) C120138, Exp 07/13; b) C120137, Exp 07/13
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-607-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026